Genome Profiling, LLC is a biopharma, medical, and biotechnology company founded by Jeb Connor. They have developed a proprietary platform that combines gDNA preparation and data analytics algorithms to analyze both genomic variant call data and epigenetic data in a single NGS run. The company leverages artificial intelligence, clinical trials, and machine learning to discover blood-based epigenetic biomarkers, which they call "epigenetic fingerprints." Their focus is on developing novel biomarkers for diagnosing and treating chronic and life-threatening diseases.